Pharma-Biotech Industry Invests More Than $12 Billion in 2012 North American Project Starts, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwire) -- 12/18/12 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- As the last moments of 2012 run their course, it is a good time to take a look at the 's capital and maintenance (MRO) project activity for the year. In January, the industry had a whopping $17 billion worth of projects set to launch construction in 2012. Almost a year later, that number has taken a dip to just more than $12 billion worth of projects that actually made it to construction as planned.
Other companies featured: (NYSE:NVS), (NYSE:JNJ), (NYSE:ABT), (NYSE:GSK), (NYSE:MRK)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at , or browse other breaking industrial news stories at .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
Joe Govreau
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 18.12.2012 - 05:15 Uhr
Sprache: Deutsch
News-ID 1181242
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SUGAR LAND, TX
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 195 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharma-Biotech Industry Invests More Than $12 Billion in 2012 North American Project Starts, an Industrial Info News Alert
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
